Search

everythinglearnresearchcommunity

for

Search:↓

Current alopecia treatments manage symptoms but don't cure, and better treatments are needed.

Subclinical hypothyroidism in women with PCOS affects thyroid and hormone interactions but not ovary structure.

Adding 0.2% taurine to Angora rabbits' diet improves wool production and overall health.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Pediatric endocrinologists should provide early fertility counseling and preservation options to young patients at risk of infertility.

The statement offers guidance for hormone therapy and surgery to help gender-incongruent adults affirm a male identity.

Menopause can cause hair loss in women due to hormonal changes, affecting their well-being and quality of life.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Older men should openly discuss sexual health with doctors to improve their quality of life.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Gray hair can potentially be managed or reversed with treatments that boost melanin production and address nutritional deficiencies.

The dietary supplement helped increase hair growth in women with hair loss.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

A patient produced cortisol after adrenalectomy, possibly due to residual tissue or other body parts making steroids.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Ayme-Gripp Syndrome was confirmed in a woman through genetic testing, highlighting the need to consider rare genetic conditions in diagnoses.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

A woman's ovarian tumor causing high testosterone was successfully removed, and her symptoms improved.

A 23-year-old woman with Hashimoto’s thyroiditis improved significantly after a 15-month integrative treatment plan.

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Post-implantation erythema is a red skin condition after medical device implantation that sometimes goes away on its own.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

AGA is a common hair loss disorder, and early diagnosis and treatment with minoxidil or finasteride can help reduce emotional distress.